A. Pintor et al., The mGlu(5) receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A(2A) receptors, NEUROREPORT, 11(16), 2000, pp. 3611-3614
The intrastriatal perfusion of the selective metabotropic glutamate (mGlu)(
5) receptor agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG, 1000 muM) s
ignificantly increased (similar to +100%, p < 0.05) glutamate extracellular
levels with respect to basal values. The potentiating effect of CHPG was p
revented by the selective mGlu(5) receptor antagonist 2-methyl-6(phenylethy
nyl)-pyridine (MPEP, 250 <mu>M)) and by the adenosine A(2A) receptor antago
nist SCH 58261 (2 mg/kg, i.p.). The results show that mGlu(5) receptors are
involved in the regulation of striatal glutamate release and suggest an in
volvement of adenosine A(2A) receptors in mGlu(5) receptor-mediated effects
. NeuroReport 11:3611-3614 (C) 2000 Lippincott Williams & Wilkins.